These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 9502810

  • 1. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.
    Pavelko KD, van Engelen BG, Rodriguez M.
    J Neurosci; 1998 Apr 01; 18(7):2498-505. PubMed ID: 9502810
    [Abstract] [Full Text] [Related]

  • 2. A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination.
    Miller DJ, Njenga MK, Murray PD, Leibowitz J, Rodriguez M.
    Int Immunol; 1996 Jan 01; 8(1):131-41. PubMed ID: 8671597
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.
    Church JS, Milich LM, Lerch JK, Popovich PG, McTigue DM.
    Glia; 2017 Jun 01; 65(6):883-899. PubMed ID: 28251686
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunoglobulins promote remyelination in the central nervous system.
    Rodriguez M, Lennon VA.
    Ann Neurol; 1990 Jan 01; 27(1):12-7. PubMed ID: 2301922
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis.
    Njenga MK, Coenen MJ, DeCuir N, Yeh HY, Rodriguez M.
    J Neurosci Res; 2000 Mar 01; 59(5):661-70. PubMed ID: 10686594
    [Abstract] [Full Text] [Related]

  • 14. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination.
    Woodruff RH, Franklin RJ.
    Neuropathol Appl Neurobiol; 1999 Jun 01; 25(3):226-35. PubMed ID: 10417664
    [Abstract] [Full Text] [Related]

  • 15. Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.
    Asakura K, Miller DJ, Pease LR, Rodriguez M.
    J Neurosci; 1998 Oct 01; 18(19):7700-8. PubMed ID: 9742140
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin.
    Wang C, Kotter MR.
    Methods Mol Biol; 2018 Oct 01; 1791():233-241. PubMed ID: 30006714
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.